Ocaratuzumab
Product Specifications
CAS Number
1169956-08-4
Target
Immunology/Inflammation related
Related Pathways
Immunology/Inflammation
Purity
0.992
Bioactivity
Ocaratuzumab (AME-133v) is an Fc-engineered antibody and humanized monoclonal antibody targeting CD20 (Kd≈100 pM), exhibiting antibody-dependent cellular cytotoxicity (ADCC) in chronic lymphocytic leukemia.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog